Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05156060 · ClinicalTrials.gov registry record · Phase 1

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

A Phase 1 study of Head and Neck Cancer and Locally Advanced Head and Neck Carcinoma, sponsored by Natalie Lockney.

Recruiting
Registry status
Phase 1
Development phase
64
Enrollment target
1
Study location

NCT05156060 is a Phase 1 study of Head and Neck Cancer and Locally Advanced Head and Neck Carcinoma that is actively recruiting participants, run by Natalie Lockney. The registered enrollment target is 64 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05156060, a Phase 1 study of Head and Neck Cancer and Locally Advanced Head and Neck Carcinoma, is actively recruiting participants, sponsored by Natalie Lockney.

RECRUITING
Registry status
Phase 1
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergoing chemoradiation.

Conditions Studied

Head and Neck Cancer Locally Advanced Head and Neck Carcinoma

Interventions

  • DRUG Ketamine
  • DRUG Gabapentin

Study Locations (1)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2022-01-24
Est. Completion 2026-12-31
Phase Phase 1

Sponsor

Natalie Lockney

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05156060

The ClinicalTrials.gov registry entry for NCT05156060 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (75% lower). The listed sponsor is Natalie Lockney, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.

NCT05156060 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT05156060 about?

NCT05156060 is a clinical study titled "Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer". This is a study to establish a safe and feasible dose for prophylactic use of a combination of gabapentin and ketamine in head and neck cancer patients undergoing chemoradiation.

What is the current status of trial NCT05156060?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 64 participants. The study started on 2022-01-24. Estimated completion is 2026-12-31.

What conditions does trial NCT05156060 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Locally Advanced Head and Neck Carcinoma.

What interventions are being tested in trial NCT05156060?

The interventions under investigation include: Ketamine (DRUG), Gabapentin (DRUG).

Who is sponsoring clinical trial NCT05156060?

This trial is sponsored by Natalie Lockney, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05156060 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Locally Advanced Head and Neck Carcinoma

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.